First Time Loading...
A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 24 050 KRW 6.18% Market Closed
Updated: Jun 3, 2024

EV/EBITDA
Enterprise Value to EBITDA

29.3
Current
-18
Median
4.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
29.3
=
Enterprise Value
1.1T
/
EBITDA
37.1B
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-24.2
2-Years Forward
EV/EBITDA
-42.1
3-Years Forward
EV/EBITDA
-36

See Also

Discover More